Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycle Control and Safety of E2/DRSP Regimens in Healthy Women
NCT00653614Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estradiol and drospirenone in contraception (6 arms), sponsored by Bayer. Primary endpoint: Number of intracyclic bleeding episodes during cycles 2 to 7 at 168 days. Started Mar 2008; status: completed.
02
Drugs
estradioldrospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00653614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653614.